Literature DB >> 4000765

Fetal lung hypoplasia associated with maternal smoking: a morphometric analysis.

M H Collins, A C Moessinger, J Kleinerman, J Bassi, P Rosso, A M Collins, L S James, W A Blanc.   

Abstract

Our recently reported animal (rat) model of maternal cigarette smoke exposure during pregnancy is characterized by fetal growth retardation and lung hypoplasia. We have further defined the fetal lungs using quantitative histologic techniques. Compared to controls, lung volume at term is reduced in the experimental animals (0.28 versus 0.33 ml, p less than 0.005). Saccules (fetal "alveoli") are reduced in number (3 X 10(6) versus 5.5 X 10(6), p less than 0.005) and increased in size (average saccular volume: 35 X 10(-9) versus 21 X 10(-9) ml, p less than 0.025). These changes in size and number are consequences of reduced formation of saccule partitions (septal crests) in the experimental lungs (volume density: 0.013 versus 0.018, p less than 0.025). Internal surface area is decreased in the hypoplastic lungs (161 versus 198 cm2, p less than 0.001). The total length of parenchymal elastic tissue is diminished (224 versus 354 M, p less than 0.05). In short the hypoplastic lungs contain fewer, larger saccules and the surface potentially available for gas exchange is reduced. These results show that maternal smoking in rats adversely modifies fetal lung growth. If these observations are applicable to humans, then reduced lung growth in children of smoking mothers may begin antenatally.

Entities:  

Mesh:

Year:  1985        PMID: 4000765     DOI: 10.1203/00006450-198519040-00018

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  35 in total

Review 1.  Fetal programming: Early-life modulations that affect adult outcomes.

Authors:  Nathan Drever; George R Saade; Egle Bytautiene
Journal:  Curr Allergy Asthma Rep       Date:  2010-11       Impact factor: 4.806

Review 2.  Epigenetics and the developmental origins of lung disease.

Authors:  Lisa A Joss-Moore; Kurt H Albertine; Robert H Lane
Journal:  Mol Genet Metab       Date:  2011-07-23       Impact factor: 4.797

Review 3.  Pulmonary Effects of Maternal Smoking on the Fetus and Child: Effects on Lung Development, Respiratory Morbidities, and Life Long Lung Health.

Authors:  Cindy T McEvoy; Eliot R Spindel
Journal:  Paediatr Respir Rev       Date:  2016-08-19       Impact factor: 2.726

4.  Sex-specific perinatal nicotine-induced asthma in rat offspring.

Authors:  Jie Liu; Erum Naeem; Jia Tian; Vincent Lombardi; Kenny Kwong; Omid Akbari; John S Torday; Virender K Rehan
Journal:  Am J Respir Cell Mol Biol       Date:  2012-09-20       Impact factor: 6.914

5.  The Role of Nicotine in the Effects of Maternal Smoking during Pregnancy on Lung Development and Childhood Respiratory Disease. Implications for Dangers of E-Cigarettes.

Authors:  Eliot R Spindel; Cindy T McEvoy
Journal:  Am J Respir Crit Care Med       Date:  2016-03-01       Impact factor: 21.405

6.  Recurrent wheezing in very preterm infants.

Authors:  D E Elder; R Hagan; S F Evans; H R Benninger; N P French
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-05       Impact factor: 5.747

7.  Perinatal factors in neonatal and pediatric lung diseases.

Authors:  Rodney D Britt; Arij Faksh; Elizabeth Vogel; Richard J Martin; Christina M Pabelick; Y S Prakash
Journal:  Expert Rev Respir Med       Date:  2013-10-03       Impact factor: 3.772

8.  Role of lifestyle in the development of chronic obstructive pulmonary disease: a review.

Authors:  Surya Kant; Barkha Gupta
Journal:  Lung India       Date:  2008-04

Review 9.  Adverse health effects of prenatal and postnatal tobacco smoke exposure on children.

Authors:  W Hofhuis; J C de Jongste; P J F M Merkus
Journal:  Arch Dis Child       Date:  2003-12       Impact factor: 3.791

10.  The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development.

Authors:  J Elliott Scott
Journal:  Tob Induc Dis       Date:  2004-03-15       Impact factor: 2.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.